comparemela.com

Latest Breaking News On - Program in relapsing multiple sclerosis ongoing - Page 1 : comparemela.com

Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update

EQS-News: Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update

EQS-News: Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Immunic Highlights 2023 Accomplishments and Upcoming Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

EQS-News: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 09.10.2023 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Reports Positi.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.